International Journal of Clinical Biochemistry and Research

Print ISSN: 2394-6369

Online ISSN: 2394-6377

CODEN : IJCBK6

International Journal of Clinical Biochemistry and Research (IJCBR) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 1094

PDF Downloaded: 706


Get Permission Santhi and Mahendran: High-sensitivity C-reactive protein, Malondialdehyde and their association with Glycated hemoglobin (HbA1c) in type 2 diabetes patients


Introduction

Type 2 diabetes mellitus is a major public health problem worldwide and accompanied by enduring vascular complications, which leads to morbidity and mortality. Inflammation plays a pivotal role in the development of type2 diabetes and vascular complications.1 Impaired insulin secretion and sensitivity leads to oxidative stress, endoplasmic reticulum stress, amyloid deposition in the pancreas, lipotoxicity and glucotoxicity.2 Studies reported that insulin resistance, inflammatory biomarkers, metabolic syndrome, dyslipidaemia, hypertension are predictive markers of cardiovascular disease (CVD) in type 2 diabetes mellitus.5, 4, 3 Chronic hy perglycemia and oxidative stress increases the pro-inflammatory proteins with infiltrated macrophages secreting inflammatory cytokines which leads to systemic inflammation.6 Hs C-reactive protein is an acute phase reactant protein produced by liver response to several cytokines and sensitive marker of low grade systemic inflammation.8, 7 Studies reported that hs - CRP directly binds to oxidized low-density lipoprotein cholesterol (LDL-C), induces plasminogen activator inhibitor-1 expression, endothelial dysfunction by which leads to cardiovascular disease (CVD).11, 10, 9

Hyperglycemia induced o xidative stress induces pro inflammatory reactants with infiltrated macrophages secreting inflammatory cytokines which leads to local and systemic inflammation.12 It has been recognized high levels of free radicals or reactive oxygen species (ROS), reactive nitrogen species (RNS) directly damage to the lipids which leads to formation of aldehydes such as malondialdehyde (MDA), propanal, hexanal, and 4-hydroxynonenal (4-HNE).14, 13 So, in this view the objective of present study was to evaluate hs -CRP, MDA levels in type 2 diabetic patients and also to explore their association with HbA1c and insulin resistance.

Materials and Methods

Fifty type 2 diabetic patients of both sexes aged between 35-45 years on oral hypoglycemic drugs, attending Department of General Medicine, Nimra Institute of Medical sciences, Jupudi, Andhra pradesh state, India were selected for present study. We excluded the patients on insulin, smokers, alcoholics, tobacco chewers, renal disease, inflammatory disorders, neoplastic disorders, thyroid disorders, liver dysfunction, history of acute myocardial infarction, stroke, and occlusive peripheral vascular disease. Fifty healthy age and sex matched subjects were selected as controls. The informed consent was obtained from all the study subjects and the study was approved by the Institutional Human Ethics Committee (IHEC). Experiments were done in accordance with Helsinki declaration of 1975.

Biochemical analysis   

Fasting ve nous blood samples were collected from the study subjects and centrifuged at 3000 rpm for 15 min. Routine laboratory investigations were carried out by standardized protocols with ERBA EM-360 fully automated analyzer. Serum insulin estimated by Enzyme Linke d Immuno Sorbe nt Assay (ELISA), HbA1c estimated by (Ion Exchange Resin method) hs- CRP was assessed by (latex turbidimetric immunoassay) , malondialdehyde (MDA) estimated by Thiobarbituric Acid Reactive Substances (TBARS) method.15 Post prandial venous blood sample collected for plasma glucose (PPG) analysis.

Homeostasis model assessment for Insulin Resistance (HOMA-IR) HOMA- IR calculated by using fasting glucose and insulin values: HOMA – IR= fasting insulin X fasting glucose (m M/L)/22.516

Statistical analysis

Statistical analysis carried out with SPSS 25.0 software and values were expressed as mean ± standard deviation, p value < 0.05 was considered as statistical significant. Pearson correlation test performed for correlation analysis.

Results

Table 1
Parameters Controls (n=50) T2DM (n=50) p value
Age 37.5±4.9 38.3±6.7 0.48
Body mass index (BMI) 24.5±1.7 27.1±2.8 0.01
Waist/Hip ratio 0.90±0.05 0.93±0.08 0.02
Systolic BP(mmHg) 115.7±6.9 118.5±10 .5 0.09
Diastolic BP (mm Hg) 78.1±5 .4 80±8.2 0.15

Comparison of baseline parameters in controls, type 2 diabetic patients

[i] Data are expressed as mean ±SD, p value <0.05 was considered statistically significant.

Table 2
Parameters Controls (n=50) T2DM (n=50) p-value
FPG (mg/dl) 81.6±8.9 135.0±12 .6 0.001
PPG(mg/dl) 105 .8±9 .6 190±21 .7 0.001
HbA1C 5.2±0.4 8.9±0.7 0.001
HOMA-IR 1.4±0.3 4.2±0.8 0.001
Serum cholesterol (mg/dl) 178.9±9.7 206.3±21 .4 0.001
Serum Triglycerides (mg/dl) 98.9±10.3 134.1±16.7 0.001
HDL cholesterol (mg/dl) 43 .0±2.4 40.2±4.8 0.02
LDL cholesterol (mg/dl) 108±10.5 134.0±15.3 0.001
Total Bilirubin(mg/dl) 0.77±0.09 0.79±0.05 0.75
Direct Bilirubin(mg/dl) 0.2±0.07 0.19±0.08 0.45
AST (IU/L) 28.6±3.5 28.8±5.4 0.67
ALT (IU/L) 28 .4±3.9 30±5.7 0.08
ALP(IU/L) 98.6±12 .1 99.4±14 .7 0.17
Serum urea(mg/dl) 23 .5±4.3 27.8±7.8 0.23
Serum creatinine(mg/dl) 0.68±0.4 0.7 7±0.5 0.322
Hs-CRP (mg/L) 1.9±0.4 4.8±1.8 0.001
MDA (μ mol/L) 1.9±0.6 6.5±1.4 0.001

Comparison of FPG, PPG, HbA1C, HOMA-IR, Lipid profile, Liver profile, Renal profile hs-CRP and MDA levels in control and type 2 diabetic subjects

[i] Data are expressed as mean ±SD, p value <0.05 was considered statistically significant.

Table 3
Parameters Correlation Coefficient(r)
BMI 0.625**
W/H ratio 0.213
FBS 0.321*
PPBS 0.203
HbA1C 0.515**
HOMA-IR 0.493**
Cholesterol 0.262
TGL 0.313*
HDL -0.356*
LDL 0.178
MDA 0.645**

Correlation between hs-CRP &measured parameters in type 2 diabetic patients

[i] **Correlation is significant at the 0.01 level (2-tailed).

[ii] *Correlation is significant at the 0.05 level (2-tailed).

Table 4
Parameters Correlation Coefficient(r)
BMI 0.398**
W/H ratio 0.293*
FBS 0.613**
PPBS 0.198
HbA1C 0.421**
HOMA-IR 0.539**
Cholesterol 0.208
TGL 0.313*
HDL -0.294*
LDL 0.126

Correlation between MDA &measured parameters in type 2 diabetic patients   

[i] *Correlation is significant at the 0.05 level (2-tailed).

[ii] **Correlation is significant at the 0.01 level (2-tailed).

Discussion

Oxidative stress stimulates the inflammatory mediators which in turn enhances the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Oxidative stress induces tumour necrosis factor alpha (TNF- α) secretion, it is linked to obesity related insulin resistance and vascular complications in type 2 diabetes mellitus.18, 17 Several studies explored that oxidative stress is not only due to free radical generation and also due to nonenzymatic protein glycosylation, auto-oxidation of glucose, impaired glutat hione metabolism, decreased antioxidant capacity.21, 20, 19 The present study has been shown significant increased hs- CRP and MDA levels in T2DM patients compared with healthy controls.

Body mass index and (BMI) and Waist hip ratio we re significantly increased in T2DM patients compared with healthy controls and also hs - CRP , MDA showed significant positive correlation with BMI. Obesity is considered as low-grade systemic inflammation, which results in metabolic derangements, insulin resistance and eventually precedes type 2 diabetes mellitus.22 Obesity enhances sympathetic drive, increase vasomotor tone and hypertension; they precedes to metabolic abnormalities such as dyslipidemia, insulin resistance, inflammation, endothelial dysfunction and organ injury.25, 24, 23

The present study also exhibits dyslipidemias in T2DM patients as reported earlier studies. High triglyceride levels and as well as decreased high-density lipoprotein (HDL) cholesterol, most likely underlying cause of increased free fatty acid flux, insulin resistance and vascular complications in type 2 diabetes mellitus.27, 26 We have observed significantly increased total cholesterol, triglycerides, LDL-C and decreased HDL-C in T2DM patients compared with healthy individuals and also hs -CRP, MDA levels were positively correlated triglycerides and negatively correlated with HDL cholesterol.

In the present study we observed hs - CRP levels showed significant positive correlation with MDA, HbA1c and HOMA-IR. Chronic inflammation is potentially unifying mechanistic cause, accompanied by activation of major inflammatory pathways such as Jun N-terminal kinases (JNK) and the transcription factor NF-kappaB along with decreased HDL-cholesterol, with impairment in reverse cholesterol transport mechanism and parallel changes in apolipoproteins, enzymes, decreased anti-oxidant capacity.30, 29, 28 Decreased HDL-Cholesterol and p hospholipids could stimulate a ccumulation of VLDL, which binds bacterial products and other toxic substances, resulting in hypertriglyceridemia. Furthermore, it promotes lipid peroxidation by peroxynitrite formation by decreasing endogenous antioxidant defenses and enhances the formation of atherosclerotic lesions.31

ROS and RNS are collectively used to describe free radicals and other non-radical reactive derivatives known as oxidants. Biologically free radicals are highly unstable molecules which are products of normal cellular metabolism. Oxidative stress induced DNA damage markers such as 8-hydroxy-2’ -deoxyguanosine (8-OHdG) and 8-oxo-7, 8-dihydro-2’ -deoxyguanosine; lipid-peroxidation products measured as thiobarbituric acid reactive substances (TBARS). In the present study we observed significantly increased MDA levels in T2DM patients compared to healthy controls and also positive correlation with HbA1c and HOMA-IR. HbA1c is widely us ed as mean glycemic index in diabetes and also useful measurement for the vascular complications. Oxidative stress plays a crucial role in pathogenesis of diabetic vascular complications.32 Chronic hyperglycemia in diabetic patients can increase production of free radicals through Amadori rearr angement.33 In general, the ROS and RNS are continuously generated in physiological conditions and are eliminated by several antioxidant enzymes. C o-existence of inflammation, increased lipid peroxidation, dyslipidemia along with hyperglycemia conditions could pathologically increase the effect of oxidative stress.35, 34 However, the decreased efficiency of cellular antioxidant mechanisms with simultaneously enhanced lipid peroxidation along with increased insulin resistance and HbA1c may contribute factors of provoking inflammatory pathways and vascular complications in type 2 diabetes mellitus.

Conclusion

Elevated hs – CRP, MDA levels are potentially important diagnostic markers for the assessment of endothelial dysfunction in type 2 diabetic patients. Tight blood glucose control, regular monitoring of hs-CRP, MDA levels within normal range might be useful for reduction of vascular complications in type 2 diabetic patients.

Source of funding

None.

Conflict of interest

None.

References

1 

Andreas Festa Ralph D’Agostino George Howard Leena Mykkänen Russell P. Tracy Steven M. Haffner Chronic Subclinical Inflammation as Part of the Insulin Resistance SyndromeCirction20001021424710.1161/01.cir.102.1.42

2 

Marc Y. Donath Steven E. Shoelson Type 2 diabetes as an inflammatory diseaseNature Rev Immunol20111129810710.1038/nri2925

3 

O O Oguntibeju Type 2 diabetes mellitus, oxidative stress and inflammation: examining the linksInt J Physiol Pathophysiol Pharmacol20191134563

4 

Alexios S. Antonopoulos Dimitris Tousoulis The molecular mechanisms of obesity paradoxCardiovascular Research20171139107410860008-6363, 1755-324510.1093/cvr/cvx106Oxford University Press (OUP)https://dx.doi.org/10.1093/cvr/cvx106

5 

B Thorand H Löwel A Schneider C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA Augsburg cohort studyArch Intern Med198416393102

6 

K E Wellen G S Hotamisligil Inflammation, stress, and diabetesJ Clin Investig200511511111120

7 

E S Ford The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination SurveyAtheroscler20031682351359

8 

A D Pradhan J E Manson N Rifai J E Buring P M Ridker Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitusJAMA20012863327334

9 

Sridevi Devaraj Dan Yan Xu Ishwarlal Jialal C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial CellsCirculation200310733984040009-7322, 1524-453910.1161/01.cir.0000052617.91920.fdOvid Technologies (Wolters Kluwer Health)https://dx.doi.org/10.1161/01.cir.0000052617.91920.fd

10 

Stephan Fichtlscherer Gunter Rosenberger Dirk H. Walter Susanne Breuer Stefanie Dimmeler Andreas M. Zeiher Elevated C-Reactive Protein Levels and Impaired Endothelial Vasoreactivity in Patients With Coronary Artery DiseaseCirc200010291000100610.1161/01.cir.102.9.1000

11 

P.M. Ridker J.E. Buring N.R. Cook N. Rifai C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14,719 initially healthy American womenACC Curr J Rev2003123333410.1016/s1062-1458(03)00157-0

12 

K E Wellen G S Hotamisligil Inflammation, stress, and diabetesJ Clin Investig200511511111119

13 

Leni Moldovan Nicanor I. Moldovan Oxygen free radicals and redox biology of organellesHistochem Cell Biol2004122439541210.1007/s00418-004-0676-y

14 

K H Cheeseman A Beavis H Esterbauer Hydroxyl-radical-induced iron-catalysed degradation of 2-deoxyribose. Quantitative determination of malondialdehydeBiochem J1988252364965310.1042/bj2520649

15 

M O Mahfouz C H Hariprasad I A Shaffie B Sadasivudu Serum malondialdehyde levels in myocardial infarction and chronic renal failureIRCS Med Sci19861411101111

16 

D. R. Matthews J. P. Hosker A. S. Rudenski B. A. Naylor D. F. Treacher R. C. Turner Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia198528741241910.1007/bf00280883

17 

Ping Zhang Xinzhi Zhang Jonathan Brown Dorte Vistisen Richard Sicree Jonathan Shaw Global healthcare expenditure on diabetes for 2010 and 2030Diabetes Res Clin Pract201087329330110.1016/j.diabres.2010.01.026

18 

Giuseppe Derosa Angela D'Angelo Aldo Bonaventura Lucio Bianchi Davide Romano Pamela Maffioli Effects of berberine on lipid profile in subjects with low cardiovascular riskExpert Opin Biol Ther201313447548210.1517/14712598.2013.776037

19 

P. Rosen P. P. Nawroth G. King W. M�ller H.-J. Tritschler L. Packer The role of oxidative stress in the onset and progression of diabetes and its complications: asummary of a Congress Series sponsored byUNESCO-MCBN, the American Diabetes Association and the German Diabetes SocietyDiabetes/Metab Res Rev200117318921210.1002/dmrr.196

20 

Prasenjit Manna Sushil K. Jain Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic StrategiesMetabolic Syndrome and Related Disorders201513104234441540-4196, 1557-851810.1089/met.2015.0095Mary Ann Liebert Inchttps://dx.doi.org/10.1089/met.2015.0095

21 

D H Lee M H Ha J H Kim Gamma-glutamyltransferase and diabetes: a 4 year follow-up studyDiabetologia200312359364

22 

Margaret F. Gregor Gökhan S. Hotamisligil Inflammatory Mechanisms in ObesityAnn Rev Immunol201129141544510.1146/annurev-immunol-031210-101322

23 

Tommy LS Visscher Jacob C Seidell The Public Health Impact of ObesityAnn Rev Public Health200122135537510.1146/annurev.publhealth.22.1.355

24 

D. Margriet Ouwens Henrike Sell Sabrina Greulich Juergen Eckel The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular diseaseJ Cell Mol Med20101492223223410.1111/j.1582-4934.2010.01141.x

25 

H Zhang J Cui C Zhang Emerging role of adipokines as mediators in atherosclerosisWorld J Cardiol2010211370376

26 

NN Jisieike-Onuigbo OA Kalu PC Onuigbo EI Unuigbe CO Oguejiofor Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra state South-East NigeriaNigerian J Clin Pract201114217117510.4103/1119-3077.84009

27 

Arshag D Mooradian Dyslipidemia in type 2 diabetes mellitusNature Reviews Endocrinology2009531501591759-5029, 1759-503710.1038/ncpendmet1066Springer Science and Business Media LLChttps://dx.doi.org/10.1038/ncpendmet1066

28 

Eduardo Esteve Wifredo Ricart José Manuel Fernández-Real Dyslipidemia and inflammation: an evolutionary conserved mechanismClin Nutr2005241163110.1016/j.clnu.2004.08.004

29 

Jiro Hirosumi Gürol Tuncman Lufen Chang Cem Z. Görgün K. Teoman Uysal Kazuhisa Maeda Michael Karin Gökhan S. Hotamisligil A central role for JNK in obesity and insulin resistanceNature200242069133333360028-0836, 1476-468710.1038/nature01137Springer Science and Business Media LLChttps://dx.doi.org/10.1038/nature01137

30 

S Nishimura I Manabe M Nagasaki CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesityNat Med200915914934

31 

Masoumeh Mehdipour Ali Taghavi Zenouz Farnaz Davoodi Narges Gholizadeh Hossein Damghani Sanaz Helli Evaluation of the Relationship between Serum Lipid Profile andOral Lichen PlanusJ Dent Res, Dent Clin, Dent Prospects20159426126610.15171/joddd.2015.046

32 

Freya Q. Schafer Garry R. Buettner Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione coupleFree Radical Biol Med200130111191121210.1016/s0891-5849(01)00480-4

33 

D. Giugliano A. Ceriello G. Paolisso Oxidative Stress and Diabetic Vascular ComplicationsDiabetes Care199619325726710.2337/diacare.19.3.257

34 

Gowri Pendyala Biju Thomas SaurabhR Joshi Evaluation of total antioxidant capacity of saliva in type 2 diabetic patients with and without periodontal disease: A case-control studyNorth Am J Med Sci201351515110.4103/1947-2714.106208

35 

J O Sardi Oxidative stress in diabetes and periodontitisAm J Med Sci201355867



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

57-61


Authors Details

T Santhi, K Balu Mahendran


Article Metrics


View Article As

 


Downlaod Files